Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure

AIMS: Sodium–glucose co‐transporter 2 (SGLT2) inhibitors improve clinical outcome in patients with heart failure (HF), but the mechanisms behind their beneficial effects are not yet fully understood. We examined the effects of empagliflozin on renal sodium and glucose handling in patients with acute...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Heart Fail
Main Authors: Boorsma, Eva M., Beusekamp, Joost C., ter Maaten, Jozine M., Figarska, Sylwia M., Danser, A.H. Jan, van Veldhuisen, Dirk J., van der Meer, Peter, Heerspink, Hiddo J.L., Damman, Kevin, Voors, Adriaan A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd. 2020
Assuntos:
Acute Heart Failure
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048437/
https://ncbi.nlm.nih.gov/pubmed/33251643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2066
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados